L Landec Corp
L
Fermé
SecteurConsommation de base
0
Résumé
Variation du prix de l'action
24h
Min
Max
Revenu | -8.9M -15M |
|---|---|
Ventes | -7.9M 23M |
Marge bénéficiaire | -64.588 |
Employés | 382 |
Recommandations | Achat Fort |
|---|---|
Prévisions sur 12 Mois | +14.84% upside |
Prochains Résultats | 9 sept. 2026 |
|---|
Capitalisation Boursière | 39M 178M |
|---|---|
Ouverture précédente | 0 |
Clôture précédente | 0 |
Sentiment de l'Actualité
By Acuity
50%
50%
51 / 131 Classement par Consumer defensive
Landec Corp Graphique
Les performances passées ne sont pas un indicateur fiable des résultats futurs.
À Propos Landec Corp
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.